Design In the obesity trial, 338 participants (mean age 48 years, 48% women, mean BMI 37.3 kg/m 2 ) were randomised (2:1:1:1:1:2:2) to retatrutide 1 mg, 4 mg (titration), 4 mg (no titration), 8 mg (slow titration), 8 mg (fast titration), 12 mg or placebo over 48 weeks [45]
For weight loss, tirzepatide generally produced larger average weight loss in clinical trials, roughly 15% to 21% across doses, versus around 15% for semaglutide
Accessed November 22, 2023
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and allows precise dose adjustment based on your response, without price increases as you optimize your regimen
This is the broadest range of GLP-1s we have tested at this price tier
[PMID: 3295441] PubMed record related to this compound for laboratory literature review